Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study

• Angela Lupattelli ,

  * E-mail: angela.lupattelli@farmasi.uio.no

  Affiliation PharmacoEpidemiology and Drug Safety Research Group, School of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

  ⨯
• Olav Spigset,

  Affiliations Department of Clinical Pharmacology, St Olav’s University Hospital, Trondheim, Norway, Department of Laboratory Medicine, Children’s and Women’s Health, Norwegian University of Science and Technology, Trondheim, Norway

  ⨯
• Leila Torgersen,

  Affiliation Division of Mental Health, Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Stephanie Zerwas,

  Affiliation UNC Center of Excellence for Eating Disorders, Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Marianne Hatle,

  Affiliation Clinic for Eating Disorders, Oslo, Norway

  ⨯
• Ted Reichborn-Kjennerud,

  Affiliations Division of Mental Health, Norwegian Institute of Public Health, Oslo, Norway, Department of Psychiatry, University of Oslo, Oslo, Norway

  ⨯
• Cynthia M. Bulik,

  Affiliations UNC Center of Excellence for Eating Disorders, Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Hedvig Nordeng

  Affiliations PharmacoEpidemiology and Drug Safety Research Group, School of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway, Division of Mental Health, Norwegian Institute of Public Health, Oslo, Norway

  ⨯